[1] | Azher, T. N., Yin, X. T., Tajfirouz, D., Huang, A. J., & Stuart, P. M. (2017). Herpes simplex keratitis: Challenges in diagnosis and clinical management. Clinical Ophthalmology, 11, 185–191. |
[2] | Bora, N. S., Jha, P., & Bora, P. S. (2008). The role of complement in ocular pathology. Seminars in Immunopathology, 30, 85–95. |
[3] | Chodosh, J., & Ung, L. (2020). Innovations in herpes simplex virus keratitis. Cornea, 39, S7–S18. |
[4] | Chodosh, J., & Ung, L. (2020). Innovations in herpes simplex virus keratitis. Cornea, 39(Suppl. 1), S7–S18. |
[5] | Conrady, C. D., Jones, H., Zheng, M., & Carr, D. J. J. (2011). The type I interferon pathway contributes to resistance to herpes simplex virus type 1 infection in the cornea by recruiting leukocytes. Journal of Biomedical Research, 25(2), 111–119. |
[6] | Conrady, C. D., Jones, H., Zheng, M., & Carr, D. J. J. (2011). The type I interferon pathway supports resistance to HSV-1 corneal infection by recruiting leukocytes. Journal of Biomedical Research, 25, 111–119. |
[7] | Doll, J. R., Hoebe, K., Thompson, R. L., & Sawtell, N. M. (2020). Resolution of herpes simplex virus reactivation in vivo results in neuronal destruction. PLoS Pathogens, 16, e1008296. |
[8] | Dunkelberger, J. R., & Song, W. C. (2010). Complement and its role in innate and adaptive immune responses. Cell Research, 20, 34–50. |
[9] | Leal, S. M., Rodino, K. G., Fowler, W. C., & Gilligan, P. H. (2021). Practical guidance for clinical microbiology laboratories: Diagnosis of ocular infections. Clinical Microbiology Reviews, 34, e0007019. |
[10] | Merle, N. S., Noe, R., Halbwachs-Mecarelli, L., Fremeaux-Bacchi, V., & Roumenina, L. T. (2015). The complement system, part II: Role in immunity. Frontiers in Immunology, 6, 257. |
[11] | Poon, S. H. L., Wong, W. H. L., Lo, A. C. Y., Yuan, H., Chen, C. F., Jhanji, V., Chan, Y. K., & Shih, K. C. (2020). Systematic review of advances in herpes simplex keratitis diagnosis. Survey of Ophthalmology. Advance online publication. |
[12] | Poon, S. H. L., Wong, W. H. L., Lo, A. C. Y., Yuan, H., Chen, C. F., Jhanji, V., Chan, Y. K., & Shih, K. C. (2021). Advances in the diagnosis of herpes simplex keratitis: A systematic review. Survey of Ophthalmology, 66, 514–530. |
[13] | Rakhmatullaeva, O. U., Shomurodov, K. E., Hadjimetov, A. A., Sadiqova, X. K., & Nazarov, Z. Z. (2021). The position of the cytokine profile and cytolysis enzymes in patients with viral hepatitis before tooth extraction. Annals of the Romanian Society for Cell Biology, 6558–6567. |
[14] | Ren, J., Anthony, F., Rouse, B. T., & Suryawanshi, A. (2023). The role of innate interferon responses on the ocular surface in herpes simplex virus-1 stromal keratitis. Pathogens, 12, 437. |
[15] | Ricklin, D., Hajishengallis, G., Yang, K., & Lambris, J. D. (2010). Complement: A key system for immune surveillance and homeostasis. Nature Immunology, 11, 785–797. |
[16] | Rustamova, S. M., Ataxodjayeva, M. A., Sh, E. V., Xadjimetov, A. A., & Axmadaliyev, N. N. (2022). Correlation relations of the composition of saliva and blood plasma in the norm. British View, 7(4). |
[17] | Sohn, J. H., et al. (2007). Complement, innate immunity, and ocular disease. Chemistry, Immunology, and Allergy, 92, 105–114. |
[18] | Sohn, J. H., Kaplan, H. J., Suk, H. J., et al. (2000). Chronic low-level complement activation within the eye is controlled by intraocular complement regulatory proteins. Investigative Ophthalmology & Visual Science, 41, 3492–3502. |
[19] | Subhan, S., Jose, R. J., Duggirala, A., Hari, R., Krishna, P., Reddy, S., & Sharma, S. (2004). Diagnosis of herpes simplex virus type 1 keratitis: Comparison of Giemsa staining, immunofluorescence, and polymerase chain reaction. Current Eye Research, 29, 209–213. |
[20] | Tam, J. C., Bidgood, S. R., McEwan, W. A., & James, L. C. (2014). Intracellular sensing of complement C3 activates cell-autonomous immunity. Science, 345, 1256070. |
[21] | Tam, J. C., Bidgood, S. R., McEwan, W. A., & James, L. C. (2014). Intracellular sensing of complement C3 activates cell-autonomous immunity. Science, 345, 1256070. |
[22] | Arduino, P. G., & Porter, S. R. (2008). Herpes simplex virus type 1 infection: Overview of clinical and pathological features. Journal of Oral Pathology and Medicine, 37, 107–121. |
[23] | Valerio, G. S., & Lin, C. C. (2019). Ocular manifestations of herpes simplex virus. Current Opinion in Ophthalmology, 30, 525–531. |
[24] | Wang, L., Wang, R., Xu, C., & Zhou, H. (2020). Pathogenesis of herpes simplex virus stromal keratitis: Immune-inflammatory response mediated by inflammatory regulators. Frontiers in Immunology, 11, 766. |
[25] | Danastas, K., Miranda-Saksena, M., & Cunningham, A. L. (2020). Interaction of herpes simplex virus type 1 with the interferon system. International Journal of Molecular Sciences, 21, 5150. |
[26] | James, S., Arfush, M., Welton, N. J., Turner, K. M., Abu-Raddad, L. J., Gottlieb, S. L., & Looker, K. J. (2020). Herpes simplex virus: Global prevalence and incidence estimates, 2016. Bulletin of the World Health Organization, 98, 315–329. |
[27] | Clark, S. J., & Bishop, P. N. (2018). The eye as a site of complement dysregulation. Seminars in Immunopathology, 40, 65–74. |
[28] | Clark, S. J., & Bishop, P. N. (2018). The eye as a site of complement dysregulation. Seminars in Immunopathology, 40, 65–74. |
[29] | Clark, S. J., & Bishop, P. N. (2018). The eye as a site of complement dysregulation. Seminars in Immunopathology, 40, 65–74. |
[30] | Koganti, R., Yadavalli, T., Naqvi, R. A., Shukla, D., & Naqvi, A. R. (2021). Pathobiology and treatment of viral keratitis. Experimental Eye Research, 205, 108483. |
[31] | Koja, L., Suryawanshi, R. K., & Shukla, D. (2019). Pathological processes activated by herpes simplex virus-1 (HSV-1) infection in the cornea. Cellular and Molecular Life Sciences, 76, 405–419. |
[32] | McCormick, I., James, S., Welton, N. J., Mayaud, P., Turner, K. M. E., Gottlieb, S. L., Foster, A., & Looker, K. J. (2022). Incidence of herpes simplex keratitis and other ocular diseases: A global review and estimates. Ophthalmic Epidemiology, 29, 353–362. |
[33] | Nazirova, Z. R., Hadjimetov, A. A., & Turakulova, D. M. (2014). The significance of immune response mediators and coagulation activity of tear fluid in children with allergic eye diseases. Russian Pediatric Ophthalmology, (2), 14–16. |
[34] | Novinskaya, A. (2021). Recent advances in the diagnosis and treatment of herpes simplex keratitis, Chapter 2. In Rodriguez-Garcia, A., & Hernandez-Camarena, H. S. (Eds.), Infectious Eye Diseases—Advances in Diagnosis and Treatment. InTechOpen. |
[35] | Ricklin, D., Hajishengallis, G., Yang, K., & Lambris, J. D. (2010). Complement: A key system for immune surveillance and homeostasis. Nature Immunology, 11, 785–797. |
[36] | Rodriguez-Garcia, A., Alfaro-Rangel, R., Bustamante-Arias, A., & Hernandez-Camarena, H. C. (2020). In vivo microstructural changes in the cornea in herpes simplex stromal keratitis: Spectral-domain optical coherence tomography analysis. Journal of Ophthalmic and Vision Research, 15(3), 279–288. |
[37] | Rowe, A. M., St Leger, A. J., Chuc, S., Dalival, D. K., Nickelbein, J. E., & Hendricks, R. L. (2013). Herpes keratitis. Progress in Retinal and Eye Research, 32, 88–101. |
[38] | Farooq, A. V., & Shukla, D. (2012). Herpes simplex epithelial and stromal keratitis: An epidemiologic update. Survey of Ophthalmology, 57, 448–462. |
[39] | Farooq, A. V., & Shukla, D. (2012). Herpes simplex epithelial and stromal keratitis: An epidemiologic update. Survey of Ophthalmology, 57, 448–462. |
[40] | Filiberti, A., Gmyrek, G. B., Berube, A. N., Royer, D. J., & Carr, D. J. (2021). An intact complement system suppresses corneal inflammation during acute primary HSV-1 infection. Scientific Reports, 11, 10247. |
[41] | Filiberti, A., Gmyrek, G. B., Berube, A. N., Royer, D. J., & Carr, D. J. (2021). An intact complement system suppresses corneal inflammation during acute primary HSV-1 infection. Scientific Reports, 11, 10247. |
[42] | Jimenez, F., Suryawanshi, A., & Rouse, B. T. (2013). Pathogenesis of herpes simplex stromal keratitis—Focusing on corneal neovascularization. Progress in Retinal and Eye Research, 33, 1–9. |
[43] | Shakhnazaryan, D., Khalil, R., Winn, K., Jeffries, C. A., Ní Gabhann-Dromgoole, J., & Murphy, C. C. (2020). Herpes simplex virus 1 affects IRF7 via ICP0, limiting type I IFN induction. Scientific Reports, 10(1), 22216. |